Overview of Novana's beta-neutral short sale of Unicycive (UNCY) ahead of its FDA decision, betting the market had mispriced regulatory risk.
Market Activities
We trade markets, driven by theses derived from our in-house deep technology research and supported by our unique asset management approach.